San Diego, CA, January 1, 2026
Robbins LLP has filed a class action lawsuit against Agilon Health, Inc. on behalf of investors who acquired the company’s securities between February 26, 2025, and August 4, 2025. The lawsuit claims Agilon Health engaged in securities fraud and failed to disclose unfavorable financial guidance, impacting investors. Those eligible to participate in the class action are encouraged to contact Robbins LLP for representation, which operates on a contingency fee basis.
San Diego, CA
Robbins LLP files class action lawsuit against Agilon Health, Inc.
San Diego, CA – Robbins LLP has initiated a class action lawsuit on behalf of investors who purchased or acquired Agilon Health, Inc. (NYSE: AGL) securities between February 26, 2025, and August 4, 2025. The lawsuit alleges that Agilon Health and certain of its officers and directors engaged in securities fraud and other unlawful business practices. Investors are encouraged to contact Robbins LLP for more information.
Allegations of Misleading Financial Guidance
The complaint asserts that Agilon Health failed to disclose that it recklessly issued 2025 financial guidance that was unlikely to be achieved, given material industry headwinds of which the company was aware. Additionally, the lawsuit alleges that Agilon Health materially overstated the immediate positive financial impact from “strategic actions” taken to reduce risk.
Background on Agilon Health, Inc.
Agilon Health, Inc. is a company that partners with physicians to transform healthcare in communities. The class action lawsuit pertains to securities purchased or acquired between February 26, 2025, and August 4, 2025.
Investor Participation and Legal Representation
Investors who purchased or acquired Agilon Health securities during the specified period may be eligible to participate in the class action. Shareholders interested in serving as lead plaintiff for the class are advised to contact Robbins LLP. All representation is on a contingency fee basis, meaning shareholders pay no fees or expenses unless there is a recovery.
Additional Information
For more information, investors can submit a form, email attorney Aaron Dumas, Jr., or call (800) 350-6003.
Agilon Health, Inc. Stock Performance
As of January 1, 2026, Agilon Health, Inc. (AGL) stock is trading at $0.6887, down $0.02570 (-3.59%) from the previous close. The intraday high was $0.72, and the intraday low was $0.6725. The latest open price was $0.7107, with an intraday volume of 6,059,968 shares.
Key Features of the Class Action Lawsuit
| Feature | Details |
|---|---|
| Class Period | February 26, 2025 – August 4, 2025 |
| Allegations | Issuing misleading financial guidance and overstating positive financial impacts from strategic actions. |
| Eligible Participants | Investors who purchased or acquired Agilon Health securities during the class period. |
| Legal Representation | Contingency fee basis; no fees or expenses unless there is a recovery. |
| Contact Information | Submit a form, email attorney Aaron Dumas, Jr., or call (800) 350-6003. |
| Agilon Health, Inc. Overview | Partners with physicians to transform healthcare in communities. |
| Current Stock Performance | Trading at $0.6887 as of January 1, 2026; down $0.02570 (-3.59%) from the previous close. |
FAQ
What is the class action lawsuit about?
The class action lawsuit alleges that Agilon Health, Inc. and certain of its officers and directors engaged in securities fraud and other unlawful business practices, including issuing misleading financial guidance for 2025.
Who is eligible to participate in the class action?
Investors who purchased or acquired Agilon Health securities between February 26, 2025, and August 4, 2025, may be eligible to participate in the class action.
How can I get more information or participate?
Investors can submit a form, email attorney Aaron Dumas, Jr., or call (800) 350-6003 for more information.
What are the terms of legal representation?
All representation is on a contingency fee basis, meaning shareholders pay no fees or expenses unless there is a recovery.
What is Agilon Health, Inc.?
Agilon Health, Inc. is a company that partners with physicians to transform healthcare in communities.
What is the current stock performance of Agilon Health, Inc.?
As of January 1, 2026, Agilon Health, Inc. (AGL) stock is trading at $0.6887, down $0.02570 (-3.59%) from the previous close.
Deeper Dive: News & Info About This Topic
HERE Resources
